Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Hybrid Medical's gel H-100 evaluated in patients with Peyronie's disease

Jan. 20, 2016

FDA accepts IND application for Tricida's TRC-101

Jan. 14, 2016

GTx initiates phase II trial of enobosarm for stress urinary incontinence

Jan. 14, 2016

Medifocus engages Kapec Design Group as lead designer of next generation of Prolieve

Jan. 14, 2016

Ardelyx reports data for RDX-022 in the treatment of hyperkalemia

Jan. 7, 2016

Lundbeck reports PDE9 inhibitors

Dec. 28, 2015

Astellas Pharma patents muscarinic M3 receptor PAMs

Dec. 24, 2015

Astellas Pharma and Kotobuki Pharmaceutical present IRAP and P-LAP inhibitors

Dec. 22, 2015

DMX-200 drug combination given FDA orphan designation for focal segmental glomerulosclerosis

Dec. 15, 2015

University of California, Oakland divulges UT-A inhibitors

Nov. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...